The covert influence of the tobacco industry on research and publication: A call to arms

Journal of Epidemiology and Community Health

Volumn 53, Issue 5, 1999, Pages 261-262

  Edwards, Richard ^a   Bhopal, Raj ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TOBACCO SMOKE;

CIGARETTE SMOKING; EDITORIAL; ETHICS; HUMAN; MEDICAL RESEARCH; PASSIVE SMOKING; PUBLIC HEALTH; TOBACCO INDUSTRY;

EID: 2442739340     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.53.5.261     Document Type: Editorial

References (21)

1. The Scientific Committee on Tobacco and Health. Report of the Scientific Committee on Tobacco and Health. London: The Stationery Office, 1998.
2. Hilts PJ. Smokescreen: the truth behind the tobacco industry cover-up. Massachusetts: Addison-Wesley Publishing, 1996.
3. Todd JS, Rennie D, McAfee RE, et al. The Brown and Williamson documents: where do we go from here? JAMA 1995; 274:256-8.
4. Action on Smoking and Health UK. Philip Morris Scandal documents show how Philip Morris and its lawyers, Covington and Burling invented and orchestrated controversy around passive smoking by infiltrating highly respected science and policy institution and by buying up scientists. Available from: URL: http://www.ash.org.uk/
5. Wadman M. Dilemmas for journals over tobacco cash. Nature 1998;394: 609.
6. Bhopal RS, Tonks A. The role of letters in reviewing research. BMJ 1994;308:1582-3.
7. Barnes DE, Bero LA. Why review articles on the health effects of passive smoking reach different conclusions. JAMA 1998;279:1566-70.
8. Rutter T. US journals veto tobacco funded research. BMJ 1996;312:11.
9. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. JAMA 1997;277:927-34.
10. Smith R. Beyond conflict of interest: transparency is the key. BMJ 1998;317:291-2.
11. Krimsky S, Rothenberg LS. Financial interest and its disclosure in scientific publications. JAMA 1998;280:225-6.
12. Horton R. Conflicts of interest in clinical research: opprobrium or obsession? Lancet 1997:349:1112-13.
13. Rothman KJ. The ethics of research sponsorship. J Clin Epidemiol 1991;44 (suppl 1):25-8S.
14. Wilkes MS, Kravitz RL. Policies, practices and attitudes of North American medical journal editors. J Gen Intern Med 1995;10:443-50.
15. Proctor C. Tobacco industry research: collaboration not confrontation, is the best response. BMJ 1998;317:333-4.
16. Weed DL, McKeown RE. Epidemiology and virtue ethics. Int J Epidemiol 1998;27:343-9.
17. Last JM. Guidelines on ethics for epidemiologists. Int J Epidemiol 1990;19: 226-9.
18. Beauchamp TL, Cook RR, Fayeweather WE, et al. Ethical guidelines for epidemiologists. J Clin Epidemiol 1991;44 (suppl 1):151-69S.
19. The IEA European Epidemiology Group. Good epidemiology practice. Proper conduct in epidemiological research. Available from: URL:http://www.dundee.ac.uk/iea/
20. Tong R. The promises and perils of pragmatism: commentary on Fins, Bacchetta and Miller. Kennedy Institute of Ethics Journal 1997;7:147-52.
21. Edwards R, Bhopal R. Biomedical journals need a concerted response against influence of the tobacco industry. BMJ 1999;318:465-6.